|4Nov 22, 4:05 PM ET

Beardsley Robert A 4

4 · Galera Therapeutics, Inc. · Filed Nov 22, 2022

Insider Transaction Report

Form 4
Period: 2022-11-21
Beardsley Robert A
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2022-11-21$1.07/sh+10,000$10,700108,191 total
  • Exercise/Conversion

    Stock Option

    2022-11-2110,00075,651 total
    Exercise: $1.07Exp: 2022-11-25Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]The option has fully vested and is currently exercisable.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION